Luye Pharma Group Ltd. (2186.HK)

HKD 2.17

(-2.25%)

Annual Balance Sheets

(In CNY)
Breakdown 2023 2022 2021 2020 2019 2018
Total Assets 25.49 Billion 24.24 Billion 22.58 Billion 20.63 Billion 19.31 Billion 17.53 Billion
Total Current Assets 10.7 Billion 10.78 Billion 10.39 Billion 9.97 Billion 9.35 Billion 8.67 Billion
Cash And Short Term Investments 8.52 Billion 5.54 Billion 5.51 Billion 5.4 Billion 5.18 Billion 4.86 Billion
Cash and Cash Equivalents 5.65 Billion 2.32 Billion 2.43 Billion 3.86 Billion 2.32 Billion 1.67 Billion
Short Term Investments 2.86 Billion 3.22 Billion 3.07 Billion 1.54 Billion 2.86 Billion 3.18 Billion
Net Receivables 2.35 Billion 1.78 Billion 1.76 Billion 1.55 Billion 1.81 Billion 1.53 Billion
Inventory 827.86 Million 772.93 Million 746.34 Million 612.3 Million 614.62 Million 585.6 Million
Other Current Assets 3 Billion 4.65 Billion 5.05 Billion 3.83 Billion 3.76 Billion 3.22 Billion
Total Non-Current Assets 14.78 Billion 13.46 Billion 12.18 Billion 10.66 Billion 9.95 Billion 8.86 Billion
Net PPE 5.12 Billion 4.9 Billion 4.59 Billion 4.33 Billion 4.21 Billion 3.19 Billion
Good Will And Intangible Assets 7.35 Billion 6.98 Billion 6.42 Billion 5.82 Billion 5.52 Billion 5.48 Billion
Good Will 1.04 Billion 1 Billion 985.41 Million 1.05 Billion 1.03 Billion 1.04 Billion
Intangible Assets 6.31 Billion 5.98 Billion 5.44 Billion 4.77 Billion 4.48 Billion 4.44 Billion
Long-Term Investments 1.96 Billion -2.1 Billion -2.48 Billion -1.46 Billion -2.79 Billion -3.1 Billion
Tax Assets 144.58 Million 113.94 Million 133.1 Million 114.74 Million 93.85 Million 98.35 Million
Other Non Current Assets 187.43 Million 3.55 Billion 3.52 Billion 1.84 Billion 2.91 Billion 3.18 Billion
Other Assets - - - - - -
Total Liabilities 11.96 Billion 13.2 Billion 13.46 Billion 12.53 Billion 9.94 Billion 9.6 Billion
Total Current Liabilities 8.13 Billion 9.48 Billion 7.33 Billion 7.23 Billion 5.54 Billion 8.2 Billion
Account Payables 767.18 Million 559.94 Million 570.89 Million 485.26 Million 298.47 Million 279.75 Million
Tax Payables 294.89 Million 256.32 Million 205.07 Million 358.08 Million 260.22 Million 223.83 Million
Short Term Debt 5.19 Billion 6.83 Billion 5.26 Billion 5.64 Billion 3.94 Billion 5.29 Billion
Deferred Revenue -18.5 Million - - - 1.28 Billion 223.83 Million
Other Current Liabilities 2.19 Billion 2.08 Billion 1.49 Billion 1.1 Billion 17.49 Million 2.4 Billion
Total Non Current Liabilities 3.82 Billion 3.72 Billion 6.13 Billion 5.29 Billion 4.39 Billion 1.4 Billion
Long-Term Debt 3.22 Billion 2.26 Billion 4.22 Billion 4.33 Billion 4.12 Billion 847.59 Million
Deferred Revenue Non Current 103.57 Million 174.96 Million 209.38 Million 185.65 Million 131.85 Million 149.62 Million
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities 445.38 Million 1.22 Billion 1.64 Billion 698.83 Million 63.69 Million 315.63 Million
Other Liabilities - - - - - -
Total Equity 13.52 Billion 11.04 Billion 9.11 Billion 8.09 Billion 9.37 Billion 7.93 Billion
Stock Holders Equity 12.53 Billion 10.17 Billion 8.48 Billion 7.89 Billion 9.22 Billion 7.8 Billion
Common Stock 486.1 Million 456.95 Million 455.83 Million 417.99 Million 420.56 Million 421.33 Million
Retained Earnings 7.38 Billion 6.66 Billion 6.06 Billion 6.2 Billion 5.68 Billion 4.83 Billion
Accumulated other comprehensive income 7.88 Billion 254.46 Million 534.03 Million 501.51 Million 381.88 Million -888.7 Million
Common Stock Equity 12.53 Billion 10.17 Billion 8.48 Billion 7.89 Billion 9.22 Billion 7.8 Billion
Capital Lease Obligation 70.64 Million 38.49 Million 41.95 Million 24.74 Million 28.95 Million 238 Thousand
Total Investments 1.96 Billion 1.11 Billion 582.19 Million 71.45 Million 71.86 Million 83.56 Million
Total Debt 8.42 Billion 9.1 Billion 9.49 Billion 9.98 Billion 8.06 Billion 6.13 Billion
Net Debt 2.76 Billion 6.78 Billion 7.05 Billion 6.11 Billion 5.74 Billion 4.46 Billion

Balance Sheet Charts